Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dexmedetomidine: a novel sedative-analgesic agent.

R Gertler1, H C Brown, D H Mitchell

  • 1Department of Anesthesiology and Pain Management, Baylor University Medical Center, Dallas, Texas 75246, USA. Ralph_Gertler10@excite.com

Proceedings (Baylor University. Medical Center)
|December 22, 2005
PubMed
Summary

Alpha2-adrenoceptor agonists like dexmedetomidine offer perioperative benefits including sedation, analgesia, and reduced anesthetic needs. These agents may help manage myocardial ischemia and pain, with potential for improved side effect profiles in newer drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Relations of the Board of Dental Examiners to the Profession.

The Dental register·2021
Same author

The Dental Aspect of Epilepsy.

The Dental register·2021
Same author

The Kurchi Treatment of Amœbic Dysentery.

The Indian medical gazette·2017
Same author

Modern technology and infectious diseases activity data: how can we use this for service planning?

Internal medicine journal·2015
Same author

Continuous non-invasive blood pressure measurement for the critically ill patient- is it on its way yet?

Minerva anestesiologica·2013
Same author

Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome.

British journal of anaesthesia·2012

Area of Science:

  • Anesthesiology and Pharmacology
  • Cardiovascular Research

Background:

  • Alpha2-adrenoceptor agonists, starting with clonidine, have expanded clinical applications.
  • Dexmedetomidine, a newer agent, is used for short-term sedation (<24 hours).

Purpose of the Study:

  • To provide background on the properties and applications of dexmedetomidine.
  • To review the benefits and expanding roles of alpha2-adrenoceptor agonists in perioperative care.

Main Methods:

  • Review of existing literature on alpha2-adrenoceptor agonists.
  • Focus on dexmedetomidine's clinical use and effects.

Main Results:

  • Alpha2-adrenoceptor agonists decrease sympathetic tone, attenuating neuroendocrine and hemodynamic responses.

Related Experiment Videos

  • They reduce anesthetic and opioid requirements, providing sedation and analgesia while preserving psychomotor function.
  • Potential benefits for perioperative myocardial ischemia prophylaxis and adjuvant treatment, with expanding roles in pain management and regional anesthesia.

    • Conclusions:

    • Alpha2-adrenoceptor agonists offer significant advantages in perioperative settings.
    • Dexmedetomidine represents a valuable tool for short-term sedation.
    • Development of more selective agents may enhance perioperative anesthesia and analgesia strategies.